3869 — Hospital of China Share Price
0.000.00%
Last trade - 00:00- HK$884.44m
- HK$1.56bn
- CNY1.43bn
- 35
- 81
- 27
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.16 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.57 | ||
| EV to EBITDA | 3.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.09% | ||
| Return on Equity | 41.39% | ||
| Operating Margin | 15.02% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 410.88 | 399.21 | 520.29 | 1,142.95 | 1,427.73 | n/a | n/a | 30.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +27.12 | +131.25 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hospital Corporation of China Limited is an investment holding company. The Company, together with its subsidiaries is principally engaged in operation and management of its privately owned hospital, Shanghai Fuhua Hospital Co., Ltd. and provision of management and consultation services to a not-for-profit hospital, Shanghai Yangsi Hospital in the People’s Republic of China.
Directors
- Shuai Chen CHM (46)
- Chuanbo Zang DGM (45)
- Wenzuo Lu EDR (71)
- Chengchuan Pu EDR (34)
- Yue Ding OTH (44)
- Meifen Le OTH (56)
- Jiayi Pang OTH (63)
- Wen Yang OTH (53)
- Min Yuchi OTH (63)
- Wing Yan Ho SEC
- Lu Liu NED
- Wenting Shi NED (31)
- Nan Wang NED
- Jinxue Dang NID (65)
- Luwen Shi NID (57)
- Xiangliang Zhou NID (36)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 21st, 2014
- Public Since
- March 16th, 2017
- No. of Employees
- 1,457
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 138,194,000
- Address
- 1602, Tower B, Jin Qiu International, BEIJING
- Web
- http://www.hcclhealthcare.com/
- Phone
- Auditors
- KPMG
Upcoming Events for 3869
Similar to 3869
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
FAQ
What is the Hospital of China share price?
As of Today at 19:10 UTC, shares in Hospital of China are trading at HK$6.40. This share price information is delayed by 15 minutes.
How has the Hospital of China share price performed this year?
Shares in Hospital of China last closed at HK$6.40 and the price had moved by -13.51% over the past 365 days. In terms of relative price strength the Hospital of China share price has underperformed the FTSE Developed Asia Pacific Index by -9.73% over the past year.
What are the analyst and broker recommendations for Hospital of China?
There is no consensus recommendation for this security.
What is the Hospital of China dividend yield?
Hospital of China does not currently pay a dividend.
Does Hospital of China pay a dividend?
Hospital of China does not currently pay a dividend.
When does Hospital of China next pay dividends?
Hospital of China does not currently pay a dividend.
How do I buy Hospital of China shares?
To buy shares in Hospital of China you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hospital of China?
As of the previous close price of HK$6.40, shares in Hospital of China had a market capitalisation of HK$884.44m.
Where are Hospital of China shares listed?
Here are the trading details for Hospital of China:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 3869
What kind of share is Hospital of China?
Based on an overall assessment of its quality, value and momentum Hospital of China is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hospital of China share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Hospital of China share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hospital of China. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -16.17%.
As of the last closing price of HK$6.40, shares in Hospital of China were trading -2.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hospital of China PE Ratio?
The Hospital of China PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$6.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hospital of China?
Hospital of China's management team is headed by:
- Shuai Chen - CHM
- Chuanbo Zang - DGM
- Wenzuo Lu - EDR
- Chengchuan Pu - EDR
- Yue Ding - OTH
- Meifen Le - OTH
- Jiayi Pang - OTH
- Wen Yang - OTH
- Min Yuchi - OTH
- Wing Yan Ho - SEC
- Lu Liu - NED
- Wenting Shi - NED
- Nan Wang - NED
- Jinxue Dang - NID
- Luwen Shi - NID
- Xiangliang Zhou - NID